Drugstore.com shares moved up 1 1/32, or 21 percent, to 5 31/32 Tuesday after it topped analysts' estimates in its second quarter and announced that it had raised $62.7 million in financing through a private placement of non-voting, preferred stock.
The online drug retailer beat the Street estimate in its second quarter despite posting a loss of $42.3 million, or 83 cents a share, on sales of $24.6 million.
First Call Corp. consensus was expecting a loss of 97 cents a share in the quarter.
Company officials said the average price per share in the placement was $4.9375. It said $23 million of the placement will initially take the form of participating, non-voting, preferred stock that will automatically convert into common stock upon shareholder approval.
The placement is being led by Integral Capital Partners. Other investors include Baron Capital and Hearst Communications, a personal investment from John Doerr, as well as participation from certain other existing investors.
Drugstore.com (Nasdaq: DSCM) shares rallied up to a 52-week high of 67 1/2 last August before falling to a low of 4 11/16 in July.
First Call Corp. consensus expects it to lose 97 cents a share in its third quarter and $3.81 a share in the fiscal year.
All nine analysts tracking the stock rate it either a "buy" or "strong buy."
Facebook wants to show it's a force for good amid scandals: The social network updates its tools for blood donations, nonprofits and mentorships.
Everything you need to know about the Qualcomm-FTC lawsuit: The antitrust case could decide how smartphones get made in the future -- and what they cost.
Discuss: Cash infusion, 2Q results spark Drugstore.com shares
Be respectful, keep it civil and stay on topic. We delete comments that violate our policy, which we encourage you to read. Discussion threads can be closed at any time at our discretion.